EHA / 14th Congress / Program overview per day / Saturday Program

Presidential Symposium

Simultaneous Sessions Clinical Trial Update Hematology-in-focus Session Lunch Debates Meet-the-Expert 7th EHA / ASH Joint Symposium EHA Business Meeting Jean Bernard Lifetime Achievement Award Presidential Symposium Plenary Session 1 Poster Session II

PRESIDENTIAL SYMPOSIUM

14:15 – 16:00, Hall 1

Chair: W Fibbe (University Medical Center, Leiden, The Netherlands), R Hehlmann (Universitätsmedizin Mannheim, Mannheim, Germany)

EHA JEAN BERNARD LIFETIME ACHIEVEMENT AWARD
Award Winner: P Mannucci (University of Milan, Milan, Italy)
INTRODUCTION
R Foà (University ‘La Sapienza’, Rome, Italy

PRESIDENTIAL SYMPOSIUM: BEST ABSTRACTS

Chairs: W Fibbe (University Medical Center, Leiden, The Netherlands), R Hehlmann (Universitätsmedizin Mannheim, Mannheim, Germany)

14:15 – 14:35

0551	CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II IS CAUSED BY MUTATIONS IN SEC23B GENE P. Bianchi, E. Fermo, C. Vercellati, C. Boschetti, W. Barcellini, A. Zanella (Foundation IRCCS Ompmare, Milan, Italy)

14:35 – 14:55

0552	HIGH-THROUGHPUT RNA INTERFERENCE SCREENING IDENTIFIES SYNTHETIC LETHALITY BETWEEN ONCOGENIC KRAS DEPENDENCY AND SUPPRESSION OF STK33 S. Fröhling, C. Scholl, I. Dunn, A. Schinzel, D. Barbie, S.Y. Kim, S. Silver, P. Tamayo, R. Wadlow, S. Ramaswamy, K. Döhner, L. Bullinger, P. Sandy, J. Boehm, D. Root, T. Jacks, W. Hahn, G. Gilliland (Brigham and Women's Hospital, Boston, USA)

14:55 – 15:15

0553	DOSE-INTENSIFIED COMBINED MODALITY TREATMENT WITH 2 CYCLES OF BEACOPP ESCALATED FOLLOWED BY 2 CYCLES OF ABVD AND INVOLVED FIELD RADIOTHERAPY (IF-RT) IS SUPERIOR TO 4 CYCLES OF ABVD AND IF-RT IN PATIENTS WITH EARLY UNFAVOURABLE HODGKIN LYMPHOMA (HL): AN ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHS M. Engert, P. Borchmann, A. Pluetschow, M. Fuchs, J. Markova, A. Lohri, Z. Kral, R. Greil, M.S. Topp, M. Villalobos, J.M. Zijlstra, M. Sökler, H. Stein, H.-T. Eich1, R.-P. Mueller (Internal Medicine I, Cologne, Germany)

0553

DOSE-INTENSIFIED COMBINED MODALITY TREATMENT WITH 2 CYCLES OF BEACOPP ESCALATED FOLLOWED BY 2 CYCLES OF ABVD AND INVOLVED FIELD RADIOTHERAPY (IF-RT) IS SUPERIOR TO 4 CYCLES OF ABVD AND IF-RT IN PATIENTS WITH EARLY UNFAVOURABLE HODGKIN LYMPHOMA (HL): AN ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHS
M. Engert, P. Borchmann, A. Pluetschow, M. Fuchs, J. Markova, A. Lohri, Z. Kral, R. Greil, M.S. Topp, M. Villalobos, J.M. Zijlstra, M. Sökler, H. Stein, H.-T. Eich1, R.-P. Mueller (Internal Medicine I, Cologne, Germany)

15:15 – 15:35

0554	DELETION OF DICER1 FROM OSTEOPROGENITOR CELLS IS SUFFICIENT TO INDUCE MYELODYSPLASIA AND HEMATOPOIETIC NEOPLASIA M.H.G.P. Raaijmakers, S. Mukherjee, S. Guo, T. Kobayashi, J. Schoonmaker, B. Ebert, F. Al-Shahrour, R. Hasserjian, E Scadden, M. Merkenschlager, C. Lin, D.T. Scadden (Massachusetts General Hospital and Harvard Medical school, Boston, USA)

15:35 – 15:55

0555	A COMMON CONSTITUTIONAL JAK2 HAPLOTYPE PREDISPOSES TO MYELOPROLIFERATIVE NEOPLASMS A.V. Jones, A. Chase, P. Beer, P. Campbell, S. Schnittger, A. Vannucchi, M. Percy, L.M. Scott, A.R. Green, C.N. Harrison, R.T. Silver, D.G. Oscier, K. Zoi, Y.L. Wang, H. Cario, H. Pahl, A. Collins, A. Reiter, F. Grand, N.C.P. Cross (WRGL, Salisbury, United Kingdom)

[

Print view ]